Another Phase III Study Supports Avastin Expansion To Ovarian Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Adding bevacizumab to chemo in first-line and maintenance therapy gives an undisclosed benefit in progression-free survival.